Abstract:Objective To construct the replication-deficient recombinant adenovirus carrying vasostatin gene and study its inhibitory effect on pancreatic cancer. Methods A cDNA clone encoding vasostatin was isolated from human skeletal muscle cDNA library by polymerase chain reaction. The shuttle plasmid, pshuttle-CMV-vasostatin, in which the amplified fragment was inserted into the downstream of the cytomegalovirus promoter, was established by ligation. After identification by digestion and sequencing, linearize the shuttle plasmid with Pme I, and then transform the linearized shuttle plasmid into E.coli BJ5183-AdEasy-1 by electroporation. The plasmid was named as pAd-CMV-vasostatin after homologous recombination and identification by kanamycin-selection and restriction digestion. The recombinant plasmid was transfected into cell 293. The recombinant adenovirus was detected by examining the presence of cytopathic effect and identified by polymerase chain reaction. Both RT-PCR and western blotting were used to identify the expression of vasostatin. The xenografted nude mice with pancreatic cancer were established to observe the inhibitory effect of vasostatin on tumor growth. The volume of xenografts was measured every three days during the 3-week treatment. The weight of xenografts was measured at the end of the 21st day. Results The PCR product was about 560 bp confirmed by agarose gel electrophoresis. The successful cloning of vasostatin into pshuttle-CMV was confirmed by restriction endonuclease analysis, and the gene of interest was identified as vasostatin by nucleotides sequencing technique. The recombinants were selected for kanamycin resistance and the recombination was confirmed by the presence of 4.5kb fragment in the restriction endonuclease analysis. The cytopathic effect present after 7 days in cell 293 transfected with linearized pAd-CMV-vasostatin. Both the cytopathic effect of cell 293 and the 560 bp PCR producet indicated the presence of the recombinant adenovirus containing vasostatin gene. The expression of vasostatin was identified by RT-PCR and western blotting. The volume and weight of xenografts in pAd-CMV-vasostatin group were significantly smaller than those in pAd-CMV-LacZ group and PBS group. Conclusion The recombinant adenovirus containing vasostatin gene was constructed successfully, and could significantly inhibit the growth of xenografted pancreatic cancer in nude mice.

Construction of Recombinant Adenovirus for the Angiogenic Inhibitor,Vasostatin,and Its Expression in Vitro

Study on Inhibitation of the Tube Formation by RNA Introduced by Adenovirus by its Interference With and Decrease of VEGF Transcription

Construction of Replication-Deficient Recombinant Adenovirus Carrying Vasostatin Gene and Its Inhibitory Effect on Pancreatic Cancer

Construction of pcDNA3-Endo eukaryon expression plasmid and angiogenesis inhibition in vitro

[Construction of a Recombinant Adenoviral Vector Expressing Human Endostatin].

Cloning and Construction of Adenovirus Expressing Human Angiopoietin-1 or Vascular Endothelial Growth Factor

Construction of Recombinant Adenovirus Coding for Vascular Endothelial Growth Factor Gene

Construction and target gene expression of adenovirus vectors containing angiogenin-1/vascular endothelial growth factor 165

Construction and Target Gene Expression of Recombinant Adenovirus Vectors Containing Vascular Endothelial Growth Factor 165 and Angiopoietin-1

Construction of Recombinant Adenovirus Expressing the Small Interfering RNA of Vascular Endothelial Growth Factor-C

[Construction and Expression of Recombinant Adenovirus Vector Carrying Human Endostatin, K5 and Endostatin-K5 Gene].

Construction of the Recombinant Human Endothelial Nitric Oxide Synthase Gene Adenovirus and Its Expression in Human Vascular Smooth Muscle Cells

Construction of hVEGF165 Recombinant Adenovirus Vector and Its Expression in HEK293 Cells

Construction of Recombinant Lentivirus Vector for Tumor Vasoinhibitory Peptide Alphastatin Gene Delivery

Construction of an Adenovirus Infected in Vitro Three-Dimensional Angiogenic Model

Cloning and Expression of Recombinant Human Angiostatin and Its Antiangiogenic Activity

Construction and Application of Recombinant Adenovirus Vector Expressing the Mouse Endostatin

Construction of recombinant adenovirus vector co-expressing angiopoietin-1 and report gene EGFP

Construction and Angiogenic Effects of Recombinant Adenovtral Vector Expressing Human Angiopoietin 1

The Construction and Characterization of a Novel Adenovirus Vector of Artificial Microrna Targeting EGFR.

Construction Recombinant Adenovirus Vector Expressing Murine Endostatin and Inhibition of Blood Endothelial Cells Growth